Journal of Korean Neurosurgical Society

The Korean Neurosurgical Society (대한신경외과학회)
권호 표지
DOI QR코드

DOI QR Code

A Recent Update of Clinical and Research Topics Concerning Adult Moyamoya Disease

  • Jeon, Jin Pyeong (Department of Neurosurgery, Hallym University College of Medicine) ;
  • Kim, Jeong Eun (Department of Neurosurgery, Seoul National University College of Medicine, Seoul National University Hospital)
  • Received : 2016.02.24
  • Accepted : 2016.07.20
  • Published : 2016.11.01
Download PDF
⟨ Previous Next ⟩

Abstract

A better understanding of moyamoya disease (MMD), such as natural clinical course, surgical outcomes and research, has been obtained. This review article focuses on an giving an update for adult MMD in the Korean population. In this paper, we mainly discuss the results of our domestic investigations including meta-analysis, and related subjects from other countries.

Keywords

References

  1. Ahn IM, Park DH, Hann HJ, Kim KH, Kim HJ, Ahn HS : Incidence, prevalence, and survival of moyamoya disease in Korea : a nationwide, population-based study. Stroke 45 : 1090-1095, 2014 https://doi.org/10.1161/STROKEAHA.113.004273
  2. Bang OY, Ryoo S, Kim SJ, Yoon CH, Cha J, Yeon JY, et al. : Adult moyamoya disease : a burden of intracranial stenosis in east asians? PLoS One 10 : e0130663, 2015 https://doi.org/10.1371/journal.pone.0130663
  3. Chen JB, Liu Y, Zhou LX, Sun H, He M, You C : Increased prevalence of autoimmune disease in patients with unilateral compared with bilateral moyamoya disease. J Neurosurg 124 : 1215-1220, 2016 https://doi.org/10.3171/2015.4.JNS142936
  4. Chen PC, Yang SH, Chien KL, Tsai IJ, Kuo MF : Epidemiology of moyamoya disease in Taiwan : a nationwide population-based study. Stroke 45 : 1258-1263, 2014 https://doi.org/10.1161/STROKEAHA.113.004160
  5. Cho WS, Chung YS, Kim JE, Jeon JP, Son YJ, Bang JS, et al. : The natural clinical course of hemodynamically stable adult moyamoya disease. J Neurosurg 122 : 82-89, 2015 https://doi.org/10.3171/2014.9.JNS132281
  6. Cho WS, Kim JE, Kim CH, Ban SP, Kang HS, Son YJ, et al. : Long-term outcomes after combined revascularization surgery in adult moyamoya disease. Stroke 45 : 3025-3031, 2014 https://doi.org/10.1161/STROKEAHA.114.005624
  7. Choi IJ, Cho SJ, Chang JC, Park SQ, Park HK : Angiographic results of indirect and combined bypass surgery for adult moyamoya disease. J Cerebrovasc Endovasc Neurosurg 14 : 216-222, 2012 https://doi.org/10.7461/jcen.2012.14.3.216
  8. Choi WS, Lee SB, Kim DS, Huh PW, Yoo DS, Lee TG, et al. : Thirteenyear experience of 44 patients with adult hemorrhagic moyamoya disease from a single institution : clinical analysis by management modality. J Cerebrovasc Endovasc Neurosurg 15 : 191-199, 2013 https://doi.org/10.7461/jcen.2013.15.3.191
  9. Fujii K, Ikezaki K, Irikura K, Miyasaka Y, Fukui M : The efficacy of bypass surgery for the patients with hemorrhagic moyamoya disease. Clin Neurol Neurosurg 99 Suppl 2 : S194-S195, 1997
  10. Fujimura M, Sonobe S, Nishijima Y, Niizuma K, Sakata H, Kure S, et al. : Genetics and biomarkers of moyamoya disease : significance of RNF213 as a susceptibility gene. J Stroke 16 : 65-72, 2014 https://doi.org/10.5853/jos.2014.16.2.65
  11. Gross BA, Du R : The natural history of moyamoya in a North American adult cohort. J Clin Neurosci 20 : 44-48, 2013 https://doi.org/10.1016/j.jocn.2012.08.002
  12. Guzman R, Lee M, Achrol A, Bell-Stephens T, Kelly M, Do HM, et al. : Clinical outcome after 450 revascularization procedures for moyamoya disease. Clinical article. J Neurosurg 111 : 927-935, 2009 https://doi.org/10.3171/2009.4.JNS081649
  13. Hallemeier CL, Rich KM, Grubb RL Jr, Chicoine MR, Moran CJ, Cross DT 3rd, et al. : Clinical features and outcome in North American adults with moyamoya phenomenon. Stroke 37 : 1490-1496, 2006 https://doi.org/10.1161/01.STR.0000221787.70503.ca
  14. Han H, Pyo CW, Yoo DS, Huh PW, Cho KS, Kim DS : Associations of moyamoya patients with HLA class I and class II alleles in the Korean population. J Korean Med Sci 18 : 876-880, 2003 https://doi.org/10.3346/jkms.2003.18.6.876
  15. Hong SH, Wang KC, Kim SK, Cho BK, Park MH : Association of HLADR and -DQ genes with familial moyamoya disease in Koreans. J Korean Neurosurg Soc 46 : 558-563, 2009 https://doi.org/10.3340/jkns.2009.46.6.558
  16. Houkin K, Kamiyama H, Abe H, Takahashi A, Kuroda S : Surgical therapy for adult moyamoya disease. Can surgical revascularization prevent the recurrence of intracerebral hemorrhage? Stroke 27 : 1342-1346, 1996 https://doi.org/10.1161/01.STR.27.8.1342
  17. Im SH, Cho CB, Joo WI, Chough CK, Park HK, Lee KJ, et al. : Prevalence and epidemiological features of moyamoya disease in Korea. J Cerebrovasc Endovasc Neurosurg 14 : 75-78, 2012 https://doi.org/10.7461/jcen.2012.14.2.75
  18. Imai H, Miyawaki S, Ono H, Nakatomi H, Yoshimoto Y, Saito N : The importance of encephalo-myo-synangiosis in surgical revascularization strategies for moyamoya disease in children and adults. World Neurosurg 83 : 691-699, 2015 https://doi.org/10.1016/j.wneu.2015.01.016
  19. Jang DK, Lee KS, Rha HK, Huh PW, Yang JH, Park IS, et al. : Clinical and angiographic features and stroke types in adult moyamoya disease. AJNR Am J Neuroradiol 35 : 1124-1131, 2014 https://doi.org/10.3174/ajnr.A3819
  20. Jeon JP, Kim JE : NMR-based metabolomics analysis of leptomeningeal carcinomatosis. Neurosurgery 75 : N12-N13, 2014
  21. Jeon JP, Yun T, Jin X, Cho WS, Son YJ, Bang JS, et al. : 1H-NMR-based metabolomic analysis of cerebrospinal fluid from adult bilateral moyamoya disease : comparison with unilateral moyamoya disease and atherosclerotic stenosis. Medicine (Baltimore) 94 : e629, 2015 https://doi.org/10.1097/MD.0000000000000629
  22. Jeon JS, Ahn JH, Moon YJ, Cho WS, Son YJ, Kim SK, et al. : Expression of cellular retinoic acid-binding protein-I (CRABP-I) in the cerebrospinal fluid of adult onset moyamoya disease and its association with clinical presentation and postoperative haemodynamic change. J Neurol Neurosurg Psychiatry 85 : 726-731, 2014 https://doi.org/10.1136/jnnp-2013-305953
  23. Jeon JS, Sheen SH, Hwang GJ, Kim HC, Kwon BJ : Feasibility of intravenous flat panel detector CT angiography for intracranial arterial stenosis. AJNR Am J Neuroradiol 34 : 129-134, 2013 https://doi.org/10.3174/ajnr.A3301
  24. Kang HS, Kim JH, Phi JH, Kim YY, Kim JE, Wang KC, et al. : Plasma matrix metalloproteinases, cytokines and angiogenic factors in moyamoya disease. J Neurol Neurosurg Psychiatry 81 : 673-678, 2010 https://doi.org/10.1136/jnnp.2009.191817
  25. Kang HS, Kim SK, Cho BK, Kim YY, Hwang YS, Wang KC, et al. : Single nucleotide polymorphisms of tissue inhibitor of metalloproteinase genes in familial moyamoya disease. Neurosurgery 58 : 1074-1080; discussion 1074-1080, 2006 https://doi.org/10.1227/01.NEU.0000215854.66011.4F
  26. Kang HS, Wang KC, Kim SK : Circulating vascular progenitor cells in moyamoya disease. J Korean Neurosurg Soc 57 : 428-431, 2015 https://doi.org/10.3340/jkns.2015.57.6.428
  27. Kawaguchi S, Okuno S, Sakaki T : Effect of direct arterial bypass on the prevention of future stroke in patients with the hemorrhagic variety of moyamoya disease. J Neurosurg 93 : 397-401, 2000 https://doi.org/10.3171/jns.2000.93.3.0397
  28. Kelly ME, Bell-Stephens TE, Marks MP, Do HM, Steinberg GK : Progression of unilateral moyamoya disease : a clinical series. Cerebrovasc Dis 22 : 109-115, 2006 https://doi.org/10.1159/000093238
  29. Kim DS, Huh PW, Kim HS, Kim IS, Choi S, Mok JH, et al. : Surgical treatment of moyamoya disease in adults : combined direct and indirect vs. indirect bypass surgery. Neurol Med Chir (Tokyo) 52 : 333-338, 2012 https://doi.org/10.2176/nmc.52.333
  30. Kim EH, Yum MS, Ra YS, Park JB, Ahn JS, Kim GH, et al. : Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease. J Neurosurg 124 : 1221-1227, 2016 https://doi.org/10.3171/2015.4.JNS142900
  31. Kim JE, Jeon JS : An update on the diagnosis and treatment of adult Moyamoya disease taking into consideration controversial issues. Neurol Res 36 : 407-416, 2014 https://doi.org/10.1179/1743132814Y.0000000351
  32. Kim JE, Kim KM, Kim JG, Kang HS, Bang JS, Son YJ, et al. : Clinical features of adult moyamoya disease with special reference to the diagnosis. Neurol Med Chir (Tokyo) 52 : 311-317, 2012 https://doi.org/10.2176/nmc.52.311
  33. Kim SJ, Heo KG, Shin HY, Bang OY, Kim GM, Chung CS, et al. : Association of thyroid autoantibodies with moyamoya-type cerebrovascular disease : a prospective study. Stroke 41 : 173-176, 2010 https://doi.org/10.1161/STROKEAHA.109.562264
  34. Kim SK, Yoo JI, Cho BK, Hong SJ, Kim YK, Moon JA, et al. : Elevation of CRABP-I in the cerebrospinal fluid of patients with Moyamoya disease. Stroke 34 : 2835-2841, 2003 https://doi.org/10.1161/01.STR.0000100159.43123.D7
  35. Kim T, Lee H, Bang JS, Kwon OK, Hwang G, Oh CW : Epidemiology of moyamoya disease in Korea : based on national health insurance service Data. J Korean Neurosurg Soc 57 : 390-395, 2015 https://doi.org/10.3340/jkns.2015.57.6.390
  36. Kim T, Oh CW, Kwon OK, Hwang G, Kim JE, Kang HS, et al. : Stroke prevention by direct revascularization for patients with adult-onset moyamoya disease presenting with ischemia. J Neurosurg 124 : 1788-1793, 2016 https://doi.org/10.3171/2015.6.JNS151105
  37. Kuriyama S, Kusaka Y, Fujimura M, Wakai K, Tamakoshi A, Hashimoto S, et al. : Prevalence and clinicoepidemiological features of moyamoya disease in Japan : findings from a nationwide epidemiological survey. Stroke 39 : 42-47, 2008 https://doi.org/10.1161/STROKEAHA.107.490714
  38. Kuroda S, Hashimoto N, Yoshimoto T, Iwasaki Y; Research Committee on Moyamoya Disease in Japan : Radiological findings, clinical course, and outcome in asymptomatic moyamoya disease : results of multicenter survey in Japan. Stroke 38 : 1430-1435, 2007 https://doi.org/10.1161/STROKEAHA.106.478297
  39. Kuroda S, Ishikawa T, Houkin K, Nanba R, Hokari M, Iwasaki Y : Incidence and clinical features of disease progression in adult moyamoya disease. Stroke 36 : 2148-2153, 2005 https://doi.org/10.1161/01.STR.0000182256.32489.99
  40. Lee SB, Kim DS, Huh PW, Yoo DS, Lee TG, Cho KS : Long-term followup results in 142 adult patients with moyamoya disease according to management modality. Acta Neurochir (Wien) 154 : 1179-1187, 2012 https://doi.org/10.1007/s00701-012-1325-1
  41. Lee SC, Jeon JS, Kim JE, Chung YS, Ahn JH, Cho WS, et al. : Contralateral progression and its risk factor in surgically treated unilateral adult moyamoya disease with a review of pertinent literature. Acta Neurochir (Wien) 156 : 103-111, 2014 https://doi.org/10.1007/s00701-013-1921-8
  42. Liu JS, Juo SH, Chen WH, Chang YY, Chen SS : A case of Graves' diseases associated with intracranial moyamoya vessels and tubular stenosis of extracranial internal carotid arteries. J Formos Med Assoc 93 : 806-809, 1994
  43. Liu W, Morito D, Takashima S, Mineharu Y, Kobayashi H, Hitomi T, et al. : Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS One 6 : e22542, 2011 https://doi.org/10.1371/journal.pone.0022542
  44. Liu W, Zhu S, Wang X, Yue X, Zhou Z, Wang H, et al. : Evaluation of angiographic changes of the anterior choroidal and posterior communicating arteries for predicting cerebrovascular lesions in adult moyamoya disease. J Clin Neurosci 18 : 374-378, 2011 https://doi.org/10.1016/j.jocn.2010.05.032
  45. Mesiwala AH, Sviri G, Fatemi N, Britz GW, Newell DW : Long-term outcome of superficial temporal artery-middle cerebral artery bypass for patients with moyamoya disease in the US. Neurosurg Focus 24 : E15, 2008
  46. Miyamoto S, Yoshimoto T, Hashimoto N, Okada Y, Tsuji I, Tominaga T, et al. : Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease : results of the Japan Adult Moyamoya Trial. Stroke 45 : 1415-1421, 2014 https://doi.org/10.1161/STROKEAHA.113.004386
  47. Miyatake S, Miyake N, Touho H, Nishimura-Tadaki A, Kondo Y, Okada I, et al. : Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease. Neurology 78 : 803-810, 2012 https://doi.org/10.1212/WNL.0b013e318249f71f
  48. Nicholson JK, Lindon JC : Systems biology : metabonomics. Nature 455 : 1054-1056, 2008 https://doi.org/10.1038/4551054a
  49. Paez MT, Yamamoto T : Single nucleotide polymorphisms of tissue inhibitor of metalloproteinase genes in familial moyamoya disease. Neurosurgery 60 : E582; author reply E582, 2007 https://doi.org/10.1227/01.NEU.0000255372.49722.6C
  50. Park YS, Min KT, Kim TG, Lee YH, Cheong HJ, Yeom IS, et al. : Age-specific eNOS polymorphisms in moyamoya disease. Childs Nerv Syst 27 : 1919-1926, 2011 https://doi.org/10.1007/s00381-011-1504-z
  51. Qian C, Yu X, Li J, Chen J, Wang L, Chen G : The efficacy of surgical treatment for the secondary prevention of stroke in symptomatic moyamoya disease : a meta-analysis. Medicine (Baltimore) 94 : e2218, 2015 https://doi.org/10.1097/MD.0000000000002218
  52. Smith ER : Moyamoya biomarkers. J Korean Neurosurg Soc 57 : 415-421, 2015 https://doi.org/10.3340/jkns.2015.57.6.415
  53. Smith ER, Scott RM : Progression of disease in unilateral moyamoya syndrome. Neurosurg Focus 24 : E17, 2008
  54. Sun H, Wilson C, Ozpinar A, Safavi-Abbasi S, Zhao Y, Nakaji P, et al. : Perioperative complications and long-term outcomes after bypasses in adults with moyamoya disease : a systematic review and meta-analysis. World Neurosurg 92 : 179-188, 2016 https://doi.org/10.1016/j.wneu.2016.04.083
  55. Suzuki J, Takaku A : Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 20 : 288-299, 1969 https://doi.org/10.1001/archneur.1969.00480090076012
  56. Tendler BE, Shoukri K, Malchoff C, MacGillivray D, Duckrow R, Talmadge T, et al. : Concurrence of Graves' disease and dysplastic cerebral blood vessels of the moyamoya variety. Thyroid 7 : 625-629, 1997 https://doi.org/10.1089/thy.1997.7.625
  57. Wurtz P, Raiko JR, Magnussen CG, Soininen P, Kangas AJ, Tynkkynen T, et al. : High-throughput quantification of circulating metabolites improves prediction of subclinical atherosclerosis. Eur Heart J 33 : 2307-2316, 2012 https://doi.org/10.1093/eurheartj/ehs020

Cited by

  1. Association of Hyperthyroidism and Thyroid Autoantibodies with Moyamoya Disease and Its Stroke Event: A Population-based Case-control Study and Meta-analysis vol.58, pp.3, 2016, https://doi.org/10.2176/nmc.oa.2017-0198
  2. Letter to the Editor. The surgical outcomes of symptomatic moyamoya disease in adults vol.129, pp.1, 2016, https://doi.org/10.3171/2017.10.jns172628
  3. Letter to the Editor. The surgical outcomes of symptomatic moyamoya disease in adults vol.129, pp.1, 2016, https://doi.org/10.3171/2017.10.jns172628
  4. Letter to the Editor. The surgical outcomes of symptomatic moyamoya disease in adults vol.129, pp.1, 2016, https://doi.org/10.3171/2017.10.jns172628
  5. Protected versus Unprotected Carotid Artery Stenting : Meta-Analysis of the Current Literature vol.61, pp.4, 2016, https://doi.org/10.3340/jkns.2017.0202.001
  6. Endovascular Treatment with Intravenous Thrombolysis versus Endovascular Treatment Alone for Acute Anterior Circulation Stroke : A Meta-Analysis of Observational Studies vol.61, pp.4, 2018, https://doi.org/10.3340/jkns.2017.0505.006
  7. Meta-Analysis of Endovascular Treatment for Acute M2 Occlusion vol.62, pp.2, 2016, https://doi.org/10.3340/jkns.2017.0299
  8. iTRAQ-based Quantitative Proteomic Analysis of Dural Tissues Reveals Upregulated Haptoglobin to be a Potential Biomarker of Moyamoya Disease vol.17, pp.None, 2016, https://doi.org/10.2174/1570164617666191210103652
  9. Stress and mood of adults with moyamoya disease: A cross‐sectional study vol.22, pp.3, 2016, https://doi.org/10.1111/nhs.12729